Regeneron Pharmaceuticals Inc (REGN)
701.85
-6.40
(-0.90%)
USD |
NASDAQ |
Dec 20, 16:00
707.00
+5.15
(+0.73%)
After-Hours: 20:00
Regeneron Pharmaceuticals Market Cap: 77.13B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Amgen Inc | 141.58B |
Eli Lilly and Co | 728.85B |
Pfizer Inc | 149.38B |
Biogen Inc | 21.34B |
AbbVie Inc | 310.27B |
Market Cap Related Metrics
PE Ratio | 17.37 |
PS Ratio | 5.834 |
PEG Ratio | 1.138 |
Price to Book Value | 2.63 |
Price to Free Cash Flow | 24.34 |
Price | 701.85 |
Earnings Yield | 5.76% |
PEGY Ratio | 1.138 |
Operating PE Ratio | 19.75 |
Normalized PE Ratio | 18.33 |